Abstract:The polyamines putrescine, spermidine and spermine represent a group of naturally occurring compounds exerting a bewildering number of biological effects, yet despite several decades of intensive research work, their exact physiological function remains obscure. Chemically these compounds are organic aliphatic cations with two (putrescine), three (spermidine) or four (spermine) amino or amino groups that are fully protonated at physiological pH values. Early studies showed that the polyamines are closely connected to the proliferation of animal cells. Their biosynthesis is accomplished by a concerted action of four different enzymes: ornithine decarboxylase, adenosylmethionine decarboxylase, spermidine synthase and spermine synthase. Out of these four enzyme, the two decarboxylases represent unique mammalian enzymes with an extremely short half life and dramatic inducibility in response to growth promoting stimuli. The regulation of ornithine decarboxylase, and to some extent also that of adenosylmethionine decarboxylase, is complex, showing features that do not always fit into the generally accepted rules of molecular biology. The development and introduction of specific inhibitors to the biosynthetic enzymes of the polyamines have revealed that an undisturbed synthesis of the polyamines is a prerequisite for animal cell proliferation to occur. The biosynthesis of the polyamines thus offers a meaningful target for the treatment of certain hyperproliferative diseases, most notably cancer. Although most experimental cancer models responds strikingly to treatment with polyamine antimetabolites--namely, inhibitors of various polyamine synthesizing enzymes--a real breakthrough in the treatment of human cancer has not yet occurred. It is, however, highly likely that the concept is viable. An especially interesting approach is the chemoprevention of cancer with polyamine antimetabolites, a process that appears to work in many experimental animal models. Meanwhile, the inhibition of polyamine accumulation has shown great promise in the treatment of human parasitic diseases, such as African trypanosomiasis.

Drug Research in Cancer Therapy Based on Polyamine Transport System

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Therapeutic poly(amino acid)s as drug carriers for cancer therapy

Polyamine homeostasis-based strategies for cancer: The role of combination regimens

Recent Advances in Fluorescent Methods for Polyamine Detection and the Polyamine Suppressing Strategy in Tumor Treatment

Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer.

Polyamine Depletion Strategies in Cancer: Remodeling the Tumor Immune Microenvironment to Enhance Anti-Tumor Responses

Drug Research Based on Polyamine Skeleton Aiming for High Selectivity and Multi-target

Recent Advances on Anticancer Protein/Peptide Delivery.

Polymeric Prodrug by Supramolecular Polymerization

Smart Polymeric Nanoparticles for Cancer Gene Delivery

Recent Advances in Anti-cancer Protein/Peptide Delivery.

Polyamines: from Molecular Biology to Clinical Applications

Biochemical Evaluation of the Anticancer Potential of the Polyamine-Based Nanocarrier Nano11047.

The Synergistic Benefit of Combination Strategies Targeting Tumor Cell Polyamine Homeostasis

Polymeric nanoparticles-Promising carriers for cancer therapy

Poly (amidoamine) (PAMAM) Dendrimer Mediated Delivery of Drug and Pdna/sirna for Cancer Therapy

Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer

Polyamine‐Responsive Morphological Transformation of a Supramolecular Peptide for Specific Drug Accumulation and Retention in Cancer Cells

Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer

Recent progress in cationic polymeric gene carriers for cancer therapy